The impact of multidrug resistance on outcomes in ventilator-associated pneumonia

Area of Science:

• Infectious Diseases
• Critical Care Medicine
• Microbiology

Background:

• Ventilator-associated pneumonia (VAP) is a significant cause of morbidity and mortality in intensive care units.
• The rise of multidrug-resistant (MDR) organisms complicates VAP treatment and outcomes.
• Identifying risk factors for MDR VAP is crucial for effective patient management.

Purpose of the Study:

• To investigate the prevalence of MDR organisms in VAP.
• To identify risk factors associated with MDR VAP.
• To determine the impact of MDR VAP on patient mortality.

Main Methods:

• Retrospective analysis of 107 patients with VAP.
• Data collection on patient demographics, prior antibiotic use, hospital stay duration, and healthcare exposure.
• Multivariate analysis to assess the association between MDR status, organism class, and mortality.

Main Results:

• MDR organisms were identified in 49% of VAP patients.
• Home antibiotic use, pre-VAP hospital stay, and healthcare exposure were associated with MDR VAP.
• Overall, MDR VAP was linked to increased mortality (P = .006).
• MDR status significantly impacted mortality differently based on organism class: no association for nonfermenting gram-negative rods, but increased risk for other organisms (HR, 6.15; P = .004).

Conclusions:

• MDR organisms are prevalent in VAP and associated with increased mortality.
• Specific organism classes, excluding nonfermenting gram-negative rods, show a significant mortality risk when MDR.
• Antibiotic stewardship and infection control measures are vital to combat MDR VAP.